anorexia/obesity

BACKGROUND 1. Field of the Invention The present invention relates to a composition for preventing, alleviating or treating obesity comprising partial fragments of Tat (Trans activator of transcription). 2. Background of Technique Wasting is a major cause of morbidity and mortality associated with

FIELD OF THE INVENTION This invention relates to the treatment and prevention of diseases associated with obsessional behaviors such as anorexia, bulimia and addiction to drugs of abuse, associated or not with stress as well as the treatment and prevention of obesity. The invention relates more

FIELD OF THE INVENTION This invention relates to the treatment and prevention of diseases associated with obsessional behaviors such as anorexia, bulimia and addiction to drugs of abuse, associated or not with stress as well as the treatment and prevention of obesity. The invention relates more

FIELD OF THE INVENTION This invention relates to the treatment and prevention of diseases associated with obsessional behaviors such as anorexia, bulimia and addiction to drugs of abuse, associated or not with stress as well as the treatment and prevention of obesity. The invention relates more

INTRODUCTION The present invention relates to a new complex receptor polypeptide LSR (Lipolysis Stimulated Receptor), characterized by its functional activities, the cloning of the cDNAs complementary to the messenger RNAs encoding each of the subunits of the multimeric complex, vectors and

1. INTRODUCTION The present invention relates to the discovery, identification and characterization of nucleotides that encode Ob receptor (ObR), a receptor protein that participates in mammalian body weight regulation. The invention encompasses obR nucleotides, host cell expression systems, ObR

1. INTRODUCTION The present invention relates to the discovery, identification and characterization of nucleotides that encode Ob receptor (ObR), a receptor protein that participates in mammalian body weight regulation. The invention encompasses obR nucleotides, host cell expression systems, ObR

INTRODUCTION The present invention relates to a new complex receptor polypeptide LSR (Lipolysis Stimulated Receptor), characterized by its functional activities, the cloning of the cDNAs complementary to the messenger RNAs encoding each of the subunits of the multimeric complex, vectors and

The present invention relates to 1,4-disubstituted piperidine compounds of general formula (I), methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans or animals. Neuropeptide Y (NPY), first isolated

FIELD OF THE INVENTION The present invention relates to a method of screening drugs (appetite (eating) stimulants, antiobesity drugs, etc.) using a receptor and a polypeptide capable of specifically binding to the receptor, compounds obtainable by the screening method, and the like. BACKGROUND

1. INTRODUCTION The present invention relates to mammalian mahogany genes, including the human mahogany gene, which are novel genes involved in the control of mammalian body weight. The invention encompasses nucleotide sequences of the mahogany gene, host cell expression systems of the mahogany

1. INTRODUCTION The present invention relates to mammalian mahogany genes, including the human mahogany gene, which are novel genes involved in the control of mammalian body weight. The invention encompasses nucleotide sequences of the mahogany gene, host cell expression systems of the mahogany

1. INTRODUCTION The present invention relates to mammalian mahogany genes, including the human mahogany gene, which are novel genes involved in the control of mammalian body weight. The invention encompasses nucleotide sequences of the mahogany gene, host cell expression systems of the mahogany

1. INTRODUCTION The present invention relates to drug screening assays, and diagnostic and therapeutic methods for the treatment of body weight disorders, such as obesity, anorexia and cachexia, involving the melanocortin 4-receptor (MC4-R). The invention also relates to compounds that modulate the

TABLE OF CONTENTS 1. INTRODUCTION 2. BACKGROUND OF THE INVENTION 2.1. THE MELANOCORTIN RECEPTORS 2.2. THE AGOUTI PROTEIN 3. SUMMARY OF THE INVENTION 3.1. DEFINITIONS 4. DESCRIPTION OF THE FIGURES 5. DETAILED DESCRIPTION OF THE INVENTION 5.1. THE ROLE OF MC4-R IN THE REGULATION OF BODY WEIGHT 5.2.